Publications
5538 Results
- Journal / Conference
- Controlled Clinical Trials 21:343-359
- Year
- 2000
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8312
Phase II clinical trial design for noncytotoxic anticancer agents for which time to disease progression is the primary endpoint
- Journal / Conference
- Lung Cancer 29(Suppl.2):186
- Year
- 2000
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9509
Current status of therapy for advanced non-small cell lung cancer: a perspective from the Southwest Oncology Group (SWOG)
- Journal / Conference
- Lung Cancer 29(Suppl.2):7
- Year
- 2000
- Research Committee(s)
- Lung
- Study Number(s)
- S9718
Gemcitabine and platinum combinations in advanced non-small cell lung cancer: an update
- Journal / Conference
- Modern Pathology 13(1):83a(#474)
- Year
- 2000
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)
A simple classification of gastric cancer
- Journal / Conference
- Proceedings of DOD Breast Cancer Research Program Meeting, vol. II, p. 779
- Year
- 2000
- Research Committee(s)
- Breast
- Study Number(s)
- S9632
An intervention to enhance well-being in women experiencing a breast cancer recurrence
- Journal / Conference
- Investigational New Drugs 17(2):169-172
- Year
- 1999
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8515
Phase II trial of menogaril in non-Hodgkin's lymphomas: A Southwest Oncology Group trial.
- Journal / Conference
- Leukemia Research 23(9):787-794
- Year
- 1999
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-8326/27
A phase II comparison of high dose ARA-C (HIDAC) vs HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia. A Southwest Oncology Group study.
- Journal / Conference
- American Journal of Clinical Oncology 22(5):446-449
- Year
- 1999
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8923
"Neo-FAC" (5-fluorouracil, doxorubicin and cyclophosphamide) for poor prognosis stage IV breast cancer: A Southwest Oncology Group Phase II study.
- Journal / Conference
- Cancer Journal from Scientific American 5(5):307-311
- Year
- 1999
- Research Committee(s)
- Head and Neck
- Study Number(s)
- SWOG-8957
Feasibility trial of postoperative radiotherapy and cisplatin followed by three courses of 5-FU and cisplatin in patients with resected head and neck cancer: a Southwest Oncology Group study
- Journal / Conference
- Journal of Urology 161:1823-1825
- Year
- 1999
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8520